, Feb. 9, 2021 /PRNewswire/
Health Canada has approved Bactiguard s urinary catheter with temperature sensor for infection prevention through an Interim Order. The approval is driven by COVID-19, as Bactiguard s catheters can reduce the risk of secondary infections for critically ill patients. Many critically ill COVID-19 patients require a urinary catheter with integrated temperature monitoring. The ICU treatment period can be 14 days or more, which means patients will require an indwelling urinary catheter for a long period of time. Each day with a catheter increases the risk of acquiring catheter-associated urinary tract infection (CAUTI) and any secondary bacterial infection in these patients could worsen an already serious condition. With Bactiguard s catheter, this risk is significantly reduced , says Dr. Stefan Grass, Chief Medical Officer and deputy CEO at Bactiguard.